Indication

Cutaneous leishmaniasis

Cutaneous leishmaniasis is a vector-borne infectious disease of the integumentary system caused by obligate intracellular protozoan parasites of the genus *Leishmania*, transmitted to humans through the bites of infected female phlebotomine sand flies. Read more about Cutaneous leishmaniasis

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Cutaneous leishmaniasis therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Cutaneous leishmaniasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Cutaneous leishmaniasis.

Cutaneous leishmaniasis is a vector-borne infectious disease of the integumentary system caused by obligate intracellular protozoan parasites of the genus *Leishmania*, transmitted to humans through the bites of infected female phlebotomine sand flies.

Pathophysiologically, the parasites infect dermal macrophages and reticuloendothelial cells, initiating a local granulomatous inflammatory cascade that develops over weeks to months.

Defining clinical features begin as localized erythematous papules or nodules that typically advance into painless, crusted ulcerative plaques with raised borders and central depressions, which may heal slowly with permanent, disfiguring scars.

The condition primarily impacts populations living in or traveling to endemic tropical, subtropical, and Mediterranean regions.

Personalize your experience

Follow Cutaneous leishmaniasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it